A Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
3 years agoA Review of CGT: Viral and Non-Viral Approaches
Cell and gene therapies have remained at the forefront of biomedical research for the last decade. While the mechanisms of these therapies differ, both approaches have shown potential across a range of conditions to alleviate symptoms or potentially cure the...
3 years ago
Future Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
3 years agoFuture Trends for Pharma and Life Sciences 2021
Given the considerable seismic shifts occurring in the pharmaceutical and life sciences sectors recently, it is no surprise that the major trends and investments of 2021 have seen a similar change in focus. Alzheimer’s Disease, genome editing and cellular therapy...
3 years ago
-SAVED-Optimising The Manufacturing Process of Drug Development to Meet Demand
Over the last decade, biopharmaceutical manufacturing has needed to evolve rapidly to keep up with clinical demand for products. Innovations in recent years have seen production increase output quantities in a shorter period of time. Adaptations to production including single-use...
3 years ago-SAVED-Optimising The Manufacturing Process of Drug Development to Meet Demand
Over the last decade, biopharmaceutical manufacturing has needed to evolve rapidly to keep up with clinical demand for products. Innovations in recent years have seen production increase output quantities in a shorter period of time. Adaptations to production including single-use...
3 years ago
Predicting Drug Toxicity: Challenges and Innovations
Failure to reach the desired safety profile is one of the main reasons for delayed drug development. Advancements in preclinical studies have seen the optimisation of in vitro assays to better predict toxicity in drug discovery. Computational methods like in...
3 years agoPredicting Drug Toxicity: Challenges and Innovations
Failure to reach the desired safety profile is one of the main reasons for delayed drug development. Advancements in preclinical studies have seen the optimisation of in vitro assays to better predict toxicity in drug discovery. Computational methods like in...
3 years ago
Weekly News Round-up – 1/4/21
In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...
3 years agoWeekly News Round-up – 1/4/21
In the news this week, GSK agrees to support NOVAVAX vaccine production to meet UK targets. In other news, Amgen Inc. confirms its agreement to acquire Rodeo Therapeutics, and COVID-19 vaccine production is boosted by expansions in production with BioNtech...
3 years ago
Weekly News Round-Up – 26/3/21
In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...
3 years agoWeekly News Round-Up – 26/3/21
In the news this week, reports urge pharmaceutical companies to exploit the benefits of synthetic data in clinical trials. In other news, FDA fears over the safety of tanezumab compromises approval for the Pfizer/Lilly pain drug, and the COSMIC database...
3 years ago
Plant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
3 years agoPlant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
3 years ago
Weekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
3 years agoWeekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
3 years ago
Weekly News Round-up – 19/2/21
PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...
3 years agoWeekly News Round-up – 19/2/21
PFIZER AND MODERNA VACCINES LESS POTENT AGAINST AGGRESSIVE COVID VARIANTS – Further evidence has arisen suggesting Pfizer and its partner BioNTech must update their current vaccines to defeat newer variants of COVID-19. In a letter published in the New England...
3 years ago
Weekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
3 years agoWeekly News Round-up – 29/1/21
In the news this week, the ongoing dispute between the UK and European Commission over vaccines entering the UK could lead to two months’ delay in herd immunity and thousands of deaths if EU plans go through. In other news,...
3 years ago